CoStAR (Costimulatory Antigen Receptor) enhancement of tumor infiltrating lymphocyte Therapy Post date November 21, 2019 ← In vitro analysis of tumor infiltrating lymphocytes engineered with costimulatory antigen receptors delivering targeted costimulation → Efficacy of adoptive therapy with tumor-infiltrating lympohocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
Instil BioInstil Bio